| Net loss | 71.69M |
| Depreciation and amortization | 3.1M |
| Stock-based compensation expense | 4.13M |
| Stock expense for shares issued pursuant to research agreement | |
| (Gain) loss on sale, abandonment/disposal or impairment of property and equipment | |
| Accrued interest on investments, net of amortization of discounts | |
| In-process research and development | |
| Goodwill impairment | |
| Loss on available-for-sale securities | |
| Other, net | 717K |
| State research and development credit exchange receivable | |
| Prepaid expenses and other current assets | -516K |
| Other assets | 307K |
| Accounts payable | -10.29M |
| Accrued expenses and other current liabilities | 6.58M |
| Other liabilities | |
| Net cash used in operating activities | |
| Purchase of marketable securities | |
| Sales and maturities of marketable securities | |
| Purchase of property and equipment | -1.14M |
| Proceeds from sale of property and equipment | 17K |
| Net cash used in investing activities | |
| Issuance of common stock and warrants | |
| Collection of Series C convertible preferred stock subscriptions receivable | |
| Issuance of Series B convertible preferred stock for cash | |
| Cash received for common stock to be issued | 0 |
| Repurchase of common stock | |
| Put shares sold to majority stockholder | |
| Borrowings under lines of credit | |
| Proceeds from notes receivables | |
| Borrowings on notes payable to related party | |
| Principal payments on notes payable to principal stockholder | |
| Borrowings on notes payable | |
| Principal payments on notes payable | |
| Proceeds from senior convertible notes | |
| Payment of employment taxes related to vested restricted stock units | |
| Net cash provided by financing activities | |
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | -23.54M |
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | 59.07M |
| CASH AND CASH EQUIVALENTS, END OF PERIOD | 35.53M |
| Cash paid for income taxes | |
| Interest paid in cash | |
| Accretion on redeemable preferred stock | |
| Issuance of common stock upon conversion of notes payable | |
| Increase in additional paid-in capital resulting from merger | |
| Issuance of common stock for notes receivable | 0 |
| Issuance of put option by stockholder | |
| Put option redemption by stockholder | |
| Issuance of Series C convertible preferred stock subscriptions | |
| Issuance of Series A redeemable convertible preferred stock | |
| Conversion of Series A redeemable convertible preferred stock | |
| Non-cash construction in progress and property and equipment | 0 |
| Cancellation of principal on note payable to related party | |